Revenue: The sum of all revenue fields included for a company's operating activities.
ALX Oncology Holdings Inc. (ALXO) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
Revenue |
-- |
$-25.95M |
|
-- |
|
-- |
|
$26.65M |
|
$-26.65M |
|
$0.70M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-26.65M |
|
$-26.70M |
|
53.45M |
|
53.45M |
|
$-0.49 |
|
$-0.49 |
|
Balance Sheet Financials | |
$85.26M |
|
$1.50M |
|
$10.06M |
|
$95.32M |
|
$18.85M |
|
$7.00M |
|
$12.06M |
|
$30.91M |
|
$64.42M |
|
$64.42M |
|
$64.42M |
|
53.51M |
|
Cash Flow Statement Financials | |
$-48.07M |
|
$49.96M |
|
$-0.16M |
|
$17.63M |
|
$19.37M |
|
$1.74M |
|
$7.35M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
0.10 |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-48.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.28% |
|
-40.28% |
|
-27.22% |
|
-36.34% |
|
$1.20 |
|
$-0.90 |
|
$-0.90 |